ARE upregulates the proteins of NAD(P)H quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO-1) in the brain substantia nigra of PD patients, indicating the activation of the Nrf2-ARE signaling pathway [12, 13]. This evidence concerns the gene NFE2L2 and Parkinson disease.